ResMed
RMD
$0.22 (-0.09%)
1D
1W
3M
1Y
5Y
ALL
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 1 day ago • RMD
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your RadarZacks Investment Research • 2 days ago • RMD
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)Zacks Investment Research • 7 days ago • RMD
Here's Why You Should Add RMD Stock to Your Portfolio NowZacks Investment Research • 14 days ago • RMD
5 Dividend Growth Stocks to Buy on Trump Win & Fed Rate CutGlobeNewsWire • 17 days ago • RMD
ResMed Announces Participation in the UBS Global Healthcare ConferenceCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.